Your browser doesn't support javascript.
loading
Pain management for post-treatment survivors of complex cancers: a qualitative study of opioids and cannabis.
Salz, Talya; Chimonas, Susan; Jinna, Sankeerth; Brens, Jessica; Kriplani, Anuja; Salner, Andrew; Rabinowits, Guilherme; Currier, Beatriz; Daly, Bobby; Korenstein, Deborah.
Affiliation
  • Salz T; Memorial Sloan Kettering Cancer Center, Department of Epidemiology & Biostatistics, New York, NY 10017, USA.
  • Chimonas S; Memorial Sloan Kettering Cancer Center, Department of Epidemiology & Biostatistics, New York, NY 10017, USA.
  • Jinna S; Memorial Sloan Kettering Cancer Center, Department of Epidemiology & Biostatistics, New York, NY 10017, USA.
  • Brens J; Memorial Sloan Kettering Cancer Center, Department of Advanced Practice Providers, New York, NY 10065, USA.
  • Kriplani A; Memorial Sloan Kettering Cancer Center, Department of Medicine, New York, NY 10065, USA.
  • Salner A; Hartford Hospital, Department of Radiation Oncology, Hartford, CT 06106, USA.
  • Rabinowits G; Moffit Cancer Center, Department of Head and Neck-Endocrine Oncology, Tampa, FL 33612, USA.
  • Currier B; Miami Cancer Institute, Department of Medicine, Miami, FL 33176, USA.
  • Daly B; Memorial Sloan Kettering Cancer Center, Department of Medicine, New York, NY 10065, USA.
  • Korenstein D; Mount Sinai Hospital, Department of Internal Medicine, New York, NY 10001, USA.
Pain Manag ; 14(2): 87-99, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38318666
ABSTRACT

Aim:

We aimed to understand experiences with opioids and cannabis for post-treatment cancer survivors. Patients &

methods:

We conducted seven focus groups among head and neck and lung cancer survivors, using standard qualitative methodology to explore themes around 1) post-treatment pain and 2) utilization, perceived benefits and perceived harms of cannabis and opioids. Results &

conclusion:

Survivors (N = 25) experienced addiction fears, stigma and access challenges for both products. Opioids were often perceived as critical for severe pain. Cannabis reduced pain and anxiety for many survivors, suggesting that anxiety screening, as recommended in guidelines, would improve traditional pain assessment. Opioids and cannabis present complex harms and benefits for post-treatment survivors who must balance pain management and minimizing side effects.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabis / Chronic Pain / Neoplasms Type of study: Guideline / Qualitative_research Limits: Humans Language: En Journal: Pain Manag Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cannabis / Chronic Pain / Neoplasms Type of study: Guideline / Qualitative_research Limits: Humans Language: En Journal: Pain Manag Year: 2024 Document type: Article Affiliation country: Country of publication: